Gossamer Bio (GOSS) Enterprise Value (2022 - 2025)
Historic Enterprise Value for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to -$180.2 million.
- Gossamer Bio's Enterprise Value rose 4489.14% to -$180.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$180.2 million, marking a year-over-year increase of 4489.14%. This contributed to the annual value of -$294.5 million for FY2024, which is 64.33% up from last year.
- According to the latest figures from Q3 2025, Gossamer Bio's Enterprise Value is -$180.2 million, which was up 4489.14% from -$212.9 million recorded in Q2 2025.
- In the past 5 years, Gossamer Bio's Enterprise Value registered a high of -$162.1 million during Q2 2023, and its lowest value of -$354.5 million during Q2 2024.
- Its 4-year average for Enterprise Value is -$261.0 million, with a median of -$257.9 million in 2025.
- As far as peak fluctuations go, Gossamer Bio's Enterprise Value crashed by 11864.97% in 2024, and later soared by 4489.14% in 2025.
- Quarter analysis of 4 years shows Gossamer Bio's Enterprise Value stood at -$255.7 million in 2022, then decreased by 15.94% to -$296.4 million in 2023, then increased by 0.64% to -$294.5 million in 2024, then surged by 38.81% to -$180.2 million in 2025.
- Its Enterprise Value stands at -$180.2 million for Q3 2025, versus -$212.9 million for Q2 2025 and -$257.9 million for Q1 2025.